Literature DB >> 31288669

Treatment Scoring of Unruptured Intracranial Aneurysms.

Seppo Juvela1.   

Abstract

Background and Purpose- The purpose was to obtain a reliable treatment score for unruptured intracranial aneurysms (UIAs) from variables known at baseline. Methods- The series included 142 patients with UIAs diagnosed between 1956 and 1978 when UIAs were not treated and were followed up until the first aneurysm rupture, death, or the last contact. Previously published UIA treatment score was recorded, and finally, a new treatment score was constructed. Results- The median follow-up time was 21.0 years (interquartile range, 10.4-31.8 years). A total of 34 patients had an aneurysm rupture during 3064 person-years of follow-up. The UIA treatment score differed slightly between those with and without an aneurysm rupture (9.4±2.8 versus 8.3±3.1, P=0.082). The receiver operating characteristics curve of the UIA treatment score for predicting rupture showed a modest area under the curve (AUC; 0.618, 95% CI, 0.502-0.733; P=0.059). The best new treatment score consisted of 4 variables: age <40 years (2 points), current smoking (2 points), UIA size ≥7 mm (3 points), and location (anterior communicating artery, 5 points; internal carotid bifurcation, 4 points; and posterior communicating artery, 2 points). Scores of 5 to 12 points were associated with high cumulative UIA rupture rates (16%-60% at 10 years and 49%-80% at 30 years), favoring UIA treatment. Scores of 1 to 4 points (3% at 10 years and 18% at 30 years) favored conservative treatment and needed additional indications for treatment. Patients with a score of 0 points should not be treated (no ruptures during 513 follow-up years). The area under the curve for this scoring was 0.755 (95% CI, 0.657-0.853; P<0.001) and was better than that of the UIA treatment score (P=0.02). Conclusions- This new simple and rapid scoring system is reliable for evaluating treatment indications with regard to the lifelong prevention of aneurysm rupture.

Entities:  

Keywords:  aneurysm; history; risk factors; smoking; subarachnoid hemorrhage

Year:  2019        PMID: 31288669     DOI: 10.1161/STROKEAHA.119.025599

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Application of unruptured aneurysm scoring systems to a cohort of ruptured aneurysms: are we underestimating rupture risk?

Authors:  James Feghali; Abhishek Gami; Risheng Xu; Christopher M Jackson; Rafael J Tamargo; Cameron G McDougall; Judy Huang; Justin M Caplan
Journal:  Neurosurg Rev       Date:  2021-04-02       Impact factor: 3.042

2.  Machine Learning and Intracranial Aneurysms: From Detection to Outcome Prediction.

Authors:  Vittorio Stumpo; Victor E Staartjes; Giuseppe Esposito; Carlo Serra; Luca Regli; Alessandro Olivi; Carmelo Lucio Sturiale
Journal:  Acta Neurochir Suppl       Date:  2022

3.  European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms.

Authors:  Nima Etminan; Diana Aguiar de Sousa; Cindy Tiseo; Romain Bourcier; Hubert Desal; Anttii Lindgren; Timo Koivisto; David Netuka; Simone Peschillo; Sabrina Lémeret; Avtar Lal; Mervyn DI Vergouwen; Gabriel Je Rinkel
Journal:  Eur Stroke J       Date:  2022-06-03

Review 4.  The Biological Effects of Smoking on the Formation and Rupture of Intracranial Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  Hanbin Wang; Luxuan Wang; Jiyue Wang; Lijian Zhang; Chunhui Li
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

5.  Timing and outcome of bystanders treatment in patients with subarachnoid hemorrhage associated with multiple aneurysms.

Authors:  Carmelo Lucio Sturiale; Anna Maria Auricchio; Vito Stifano; Rosario Maugeri; Alessio Albanese
Journal:  Neurosurg Rev       Date:  2022-05-03       Impact factor: 2.800

6.  Warning Signs in the Era of Unruptured Intracranial Aneurysms: Report on 2 Cases of Fatal Aneurysmal Hemorrhage.

Authors:  Katarzyna Wójtowicz; Przemysław Kunert; Łukasz Przepiórka; Andrzej Marchel
Journal:  Cerebrovasc Dis Extra       Date:  2021-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.